-
FDA Approves Trial for Ibudilast
The FDA has approved the design and protocol of a new pivotal Phase2b/3 trial that will evaluate the potential of ibudilast to treat ALS patients. Read more about this trial here.
Are you interested in following this trial?
-
2 Replies
-
<p style=”text-align: center;”>We want a drug to treat ALS ! We are dying</p>
-
I agree with you Mirella – – we need a faster track to discovering treatments for ALS.
Log in to reply.